During today's hearing, the Bench highlighted that when patients undergo treatment under government-sponsored welfare schemes, corporate hospitals obtain full reimbursement from the exchequer based on these artificially inflated MRPs.
"In corporate hospitals... ₹27,000 MRP.
If that patient is taking treatment under a government scheme, who reimburses?
Appearing for the Central government, Solicitor General (SG) Tushar Mehta acknowledged the issue, submitting that the government needs to find a balanced resolution.
Some way that balances equities... let me sit with the officers and then respond," SG Mehta submitted, requesting a short adjournment.
During today's hearing, the Bench highlighted that when patients undergo treatment under government-sponsored welfare schemes, corporate hospitals obtain full reimbursement from the exchequer based on these artificially inflated MRPs.
"In corporate hospitals... ₹27,000 MRP. PTR is around ₹3,000. Just see the difference. Corporate hospital says you have to buy from our chemist. If you bring it from outside, we are not assuring treatment. If that patient is taking treatment under a government scheme, who reimburses? The taxpayer pays. Why not uniform criteria?" the Bench asked.
Appearing for the Central government, Solicitor General (SG) Tushar Mehta acknowledged the issue, submitting that the government needs to find a balanced resolution.
"We will have to find a way out. Some way that balances equities... let me sit with the officers and then respond," SG Mehta submitted, requesting a short adjournment.
